EastPharma reported sales results for the nine months of 2015. For the period, the company reported revenue of USD 158.3 million, up 1.1% from USD 156.6 million for the same period in 2014. Sales increase in US Dollar terms was mainly due to increased volumes in Human Pharma products business.
1st Jan change | Capi. | |
---|---|---|
+25.40% | 45.54B | |
+34.52% | 24.51B | |
+27.12% | 16.48B | |
+21.19% | 14.66B | |
+71.91% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |